Related Experiment Videos
Sepharose-unbinding ricin E as a source for ricin A chain immunotoxin
1Drug Targeting Laboratory, College of Pharmacy, SungKyunKwan University, 300 Chonchon-dong, Jangan-ku, 440-746, Suwon City, South Korea.
Journal of Immunological Methods
|February 28, 2001
Summary
Ricin A chain from ricin E (RTA(E)) is a viable alternative to RTA from ricin D (RTA(D)) for immunotoxin development. Characterization revealed no significant differences in properties or efficacy, supporting RTA(E) use in research.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Immunotoxins are crucial for targeted cancer therapy.
- Ricin A chain (RTA) is a potent cytotoxic component used in immunotoxins.
- Different ricin variants exist, necessitating characterization for specific applications.
Purpose of the Study:
- To evaluate Sepharose-unbinding ricin E's ricin A chain (RTA(E)) as a source material for immunotoxin studies.
- To compare RTA(E) with Sepharose-binding ricin D's ricin A chain (RTA(D)).
Main Methods:
- Capillary electrophoresis to separate RTA subunits (A1 and A2).
- Isoelectric point determination for subunits.
- Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry for molecular mass analysis.
- Preparation and in vitro testing of Anti-CD4-RTA immunotoxins.
Main Results:
- RTA(E) and RTA(D) subunits showed similar isoelectric points and molecular masses.
- No significant differences were observed in cell surface affinity and cytotoxicity between RTA(E) and RTA(D).
- Anti-CD4-RTA(E) immunotoxin demonstrated comparable in vitro cytotoxic effects to Anti-CD4-RTA(D) against CEM cells.
Conclusions:
- Ricin A chain from ricin E is a variant of RTA(D).
- RTA(E) can be utilized as a suitable source material for RTA in immunotoxin research.
- This finding expands options for immunotoxin development and research.